Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 13295-13296 [2019-06602]
Download as PDF
Federal Register / Vol. 84, No. 65 / Thursday, April 4, 2019 / Notices
professionals and the public about HIV/
AIDS, Viral Hepatitis and other STDs.
Matters To Be Considered: The agenda
will include discussions on (1)
Prevention of Perinatal HIV, Viral
Hepatitis, and Congenital Syphilis:
Examples from the Field; (2) Ending the
HIV Epidemic—Collaborating Across
Geographic Boundaries and
Responsibilities; (3) Hepatitis C Virus
(HCV) Elimination: Institutional
Models; (4) Dating Apps and STD/HIV
Risk: Opportunities for Promotion,
Prevention, Monitoring and Evaluation;
and (5) Updates from Workgroups.
Agenda items are subject to change as
priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–06607 Filed 4–3–19; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Mine Safety and Health Research
Advisory Committee (MSHRAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Mine Safety and Health Research
Advisory Committee (MSHRAC). This
meeting is open to the public, limited
only by the space available. The meeting
room accommodates approximately 75
people. If you wish to attend in person
or by phone, please contact Marie
Chovanec by email at MChovanec@
cdc.gov or by phone at 412–386–5302 at
least 5 business days in advance of the
meeting.
DATES: The meeting will be held on May
6, 2019, 8:30 a.m.–4:30 p.m., EDT and
on May 7, 2019, 8 a.m.–120 p.m. EDT.
ADDRESSES: NIOSH Pittsburgh Campus,
Building 140, Room 140MP, 626
Cochrans Mill Road, Pittsburgh, PA
15236, United States.
jbell on DSK30RV082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:25 Apr 03, 2019
Jkt 247001
FOR FURTHER INFORMATION CONTACT:
Jeffrey H. Welsh, Designated Federal
Officer, MSHRAC, NIOSH, CDC, 626
Cochrans Mill Road, Pittsburgh, PA
15236, telephone 412–386–4040; email
juw5@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This committee is charged
with providing advice to the Secretary,
Department of Health and Human
Services; the Director, CDC; and the
Director, NIOSH, on priorities in mine
safety and health research, including
grants and contracts for such research,
30 U.S.C. 812(b)(2), Section 102(b)(2).
Matters To Be Considered: The agenda
will include discussions on mining
safety and health research projects and
outcomes, including updates from two
MSHRAC Workgroups, the Health
Advisory in the Mining Program
Workgroup and the Metal Mining
Automation and Advanced
Technologies Workgroup; industrial
minerals sector research priorities;
translation of hand-arm vibration to the
hearing canal; ground control challenges
in Nevada weak rock; respirable dust
control technology; EXAMiner hazard
recognition training; slips, trips and
falls research; health and safety
management systems through safety
climate; and lithium ion battery
research. The meeting will also include
updates from the NIOSH Associate
Director for Mining, the Spokane
Mining Research Division, the
Pittsburgh Mining Research Division,
the National Personal Protective
Technology Laboratory and the
Respiratory Health Division. Agenda
items are subject to change as priorities
dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–06604 Filed 4–3–19; 8:45 am]
BILLING CODE 4163–19–P
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
13295
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting
is open to the public, limited only by
the space available. The meeting space
accommodates approximately 150
people and the audio conference line
has 150 ports for callers. The public is
welcome to submit written comments in
advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcome to
listen to the meeting by joining the
teleconference (information below).
DATES: The meeting will be held on
April 17, 2019 from 8:30 a.m. to 6 p.m.,
EDT. A public comment session will be
held on April 17, 2019 at 6 p.m. and
conclude at 7 p.m. or following the final
call for public comment, whichever
comes first.
ADDRESSES: Pittsburgh Marriott City
Center, 112 Washington Place, Pittsburg,
PA 15219; Phone: (412) 471–4000, Fax:
(412) 394–1017 and audio conference
call via FTS Conferencing. The USA
toll-free dial-in number is 1 (866) 659–
0537; the pass code is 9933701. Web
conference by Skype: Meeting
CONNECTION: https://
webconf.cdc.gov/zab6/yzdq02pl?sl=1.
FOR FURTHER INFORMATION CONTACT:
Theodore Katz, MPA, Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road NE, Mailstop E–20,
Atlanta, Georgia 30329, Telephone (513)
533–6800, Toll Free 1(800) CDC–INFO,
Email ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
SUMMARY:
E:\FR\FM\04APN1.SGM
04APN1
jbell on DSK30RV082PROD with NOTICES
13296
Federal Register / Vol. 84, No. 65 / Thursday, April 4, 2019 / Notices
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the CDC. NIOSH
implements this responsibility for CDC.
The Advisory Board’s charter was
issued on August 3, 2001, renewed at
appropriate intervals, rechartered under
Executive Order 13811 on February 12,
2018, and will terminate on September
30, 2019.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters To Be Considered: The agenda
will include discussions on the
following: NIOSH Program Update;
Department of Labor Program Update;
Department of Energy Program Update;
SEC Petitions Update; SEC Petitions for:
Sandia National Laboratory
(Albuquerque, New Mexico, 1997–
2011), Area IV Santa Susanna Field
Laboratory (Ventura County, California,
1991–1993), Superior Steel Company
(Carnegie, Pennsylvania), and Idaho
National Laboratory (Scoville, Idaho,
1963–1970); and a Board Work Session.
Agenda items are subject to change as
priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
VerDate Sep<11>2014
17:25 Apr 03, 2019
Jkt 247001
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–06602 Filed 4–3–19; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Interagency Committee on Smoking
and Health (ICSH); Notice of Charter
Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of charter renewal.
AGENCY:
This gives notice under the
Federal Advisory Committee Act of
October 6, 1972, that the Interagency
Committee on Smoking and Health,
Department of Health and Human
Services, has been renewed for a 2-year
period through March 20, 2021.
FOR FURTHER INFORMATION CONTACT:
Simon McNabb, Designated Federal
Officer, Interagency Committee on
Smoking and Health, Centers for Disease
Control and Prevention, Department of
Health and Human Services, Patriot’s
Plaza, 395 E Street SW, M/S P06,
Washington, DC 20201, telephone (202)
245–0550, Email: BOL1@cdc.gov.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
SUMMARY:
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–06605 Filed 4–3–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2016–N–1593]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Medical Device
Accessories
AGENCY:
Food and Drug Administration,
HHS.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on information
collections regarding medical device
accessories requests.
DATES: Submit either electronic or
written comments on the collection of
information by June 3, 2019.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before June 3, 2019.
The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of June 3, 2019. Comments
received by mail/hand delivery/courier
(for written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
E:\FR\FM\04APN1.SGM
04APN1
Agencies
[Federal Register Volume 84, Number 65 (Thursday, April 4, 2019)]
[Notices]
[Pages 13295-13296]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06602]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or the
Advisory Board), National Institute for Occupational Safety and Health
(NIOSH)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting is open to the public, limited only
by the space available. The meeting space accommodates approximately
150 people and the audio conference line has 150 ports for callers. The
public is welcome to submit written comments in advance of the meeting,
to the contact person below. Written comments received in advance of
the meeting will be included in the official record of the meeting. The
public is also welcome to listen to the meeting by joining the
teleconference (information below).
DATES: The meeting will be held on April 17, 2019 from 8:30 a.m. to 6
p.m., EDT. A public comment session will be held on April 17, 2019 at 6
p.m. and conclude at 7 p.m. or following the final call for public
comment, whichever comes first.
ADDRESSES: Pittsburgh Marriott City Center, 112 Washington Place,
Pittsburg, PA 15219; Phone: (412) 471-4000, Fax: (412) 394-1017 and
audio conference call via FTS Conferencing. The USA toll-free dial-in
number is 1 (866) 659-0537; the pass code is 9933701. Web conference by
Skype: Meeting CONNECTION: https://webconf.cdc.gov/zab6/yzdq02pl?sl=1.
FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road NE, Mailstop E-20, Atlanta,
Georgia 30329, Telephone (513) 533-6800, Toll Free 1(800) CDC-INFO,
Email [email protected].
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include
[[Page 13296]]
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health and
Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final rule,
advice on the scientific validity and quality of dose estimation and
reconstruction efforts being performed for purposes of the compensation
program, and advice on petitions to add classes of workers to the
Special Exposure Cohort (SEC). In December 2000, the President
delegated responsibility for funding, staffing, and operating the
Advisory Board to HHS, which subsequently delegated this authority to
the CDC. NIOSH implements this responsibility for CDC.
The Advisory Board's charter was issued on August 3, 2001, renewed
at appropriate intervals, rechartered under Executive Order 13811 on
February 12, 2018, and will terminate on September 30, 2019.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advising the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters To Be Considered: The agenda will include discussions on
the following: NIOSH Program Update; Department of Labor Program
Update; Department of Energy Program Update; SEC Petitions Update; SEC
Petitions for: Sandia National Laboratory (Albuquerque, New Mexico,
1997-2011), Area IV Santa Susanna Field Laboratory (Ventura County,
California, 1991-1993), Superior Steel Company (Carnegie,
Pennsylvania), and Idaho National Laboratory (Scoville, Idaho, 1963-
1970); and a Board Work Session. Agenda items are subject to change as
priorities dictate.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-06602 Filed 4-3-19; 8:45 am]
BILLING CODE 4163-19-P